Enzo Biochem Inc. (ENZ)

6.15
0.01 0.16
NYSE : Health Technology
Prev Close 6.16
Open 6.16
Day Low/High 6.13 / 6.23
52 Wk Low/High 5.35 / 12.04
Volume 146.90K
Avg Volume 189.90K
Exchange NYSE
Shares Outstanding 47.00M
Market Cap 289.06M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Relative Strength Alert For Enzo Biochem

Relative Strength Alert For Enzo Biochem

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Second Quarter And First Half Results

Enzo Biochem Reports Second Quarter And First Half Results

Enzo Biochem Inc. (NYSE:ENZ) today announced results for the fiscal quarter and six months ended January 31, 2018.

Enzo Biochem Schedules Teleconference To Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 second quarter results Tuesday, March 13, 2018, at 8:30 AM E.

Enzo Biochem Becomes Oversold (ENZ)

Enzo Biochem Becomes Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Enzo Biochem At $5, Earn 9.2% Annualized Using Options

Commit To Buy Enzo Biochem At $5, Earn 9.2% Annualized Using Options

Investors eyeing a purchase of Enzo Biochem, Inc. stock, but tentative about paying the going market price of $6.72/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology.

Enzo Biochem is Now Oversold (ENZ)

Enzo Biochem is Now Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem Reports Improved First Quarter Results

Enzo Biochem Inc. (NYSE:ENZ) today reported improved operating results for the first fiscal quarter ended October 31, 2017, including year over year double digit revenue growth at Enzo Clinical Labs.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2018 Results Friday, December 8, 2017 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss First Quarter 2018 Results Friday, December 8, 2017 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 first quarter results Friday, December 8, 2017, at 8:30 AM E.

Closing out of a Biotech Position

Enzo Biochem has had some worrying action in price.

Doubling Down on This Biotech Name

Despite the earnings miss, this name has great promise -- and we are doubling our stake on this weakness.

Stocks Under $10 Weekly Summary

We exited two positions today following a tough week for small-cap stocks.

Relative Strength Alert For Enzo Biochem

Relative Strength Alert For Enzo Biochem

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Under $10 Weekly Summary

Last week, we increased our holdings in one position and added 2 Bullpen names.

Stocks Under $10 Weekly Summary

We used price declines to scale into several holdings as small-caps underperformed the overall market.

What Enzo Biochem's Good News Means for Our Position

Keep a close eye on this one, and establish a stop-loss order at or around $9.50.

Stocks Under $10 Weekly Summary

This week brings earnings from 5 portfolio holdings as the market continues to shrug off potential negatives.

Enzo Biochem Enters Oversold Territory (ENZ)

Enzo Biochem Enters Oversold Territory (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Under $10 Weekly Summary

We took some profits and added a Bullpen name, among other moves, during a rough week for a few portfolio names.

Stocks Under $10 Weekly Summary

We added to one name during a stellar week for the majority of the portfolio.

An Ocean Shipper, a Biotech Concern and Other Stocks That Look Good Short

UTHR, ENZ, HCI, SBLK and EVI all recently were downgraded by TheStreet's Quant Ratings.

Stocks Under $10 Weekly Summary

We took a healthy profit trimming one name and added to three other positions last week.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABG, CCRN, CREE, DAKT, DVD, GNRC, GVP, HMN Downgrades: ENZ, PSEC, WCFB Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Enzo Biochem Reports Increase In Revenues And Profitable Fourth Quarter

Enzo Biochem Reports Increase In Revenues And Profitable Fourth Quarter

Enzo Biochem Inc. (NYSE:ENZ) today reported increased results for the fourth quarter and fiscal year ended July 31, 2017, along with advances in its corporate strategy in molecular diagnostics products and services.

Stocks Under $10 Weekly Summary

We added a digital security name to the Bullpen during a mixed week for the portfolio.

Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 At 8:30 AM E.T.

Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 At 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2017 fourth quarter results Thursday, September 28, 2017, at 8:30 AM E.

Enzo Biochem is Now Oversold (ENZ)

Enzo Biochem is Now Oversold (ENZ)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Under $10 Weekly Summary

We initiated 2 new positions and jettisoned another over the last week.

Stocks Under $10 Weekly Summary

We remain cautious during this historically volatile month for the market.

Stocks Under $10 Weekly Summary

We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.

TheStreet Quant Rating: C- (Hold)